You are here: Industry Insights > COVID-19

News List

OncoImmune’s SACCOVID demonstrates significant therapeutic efficacy in Covid-19 trial pharmaceutical-business-review
September 30, 2020
OncoImmune announced that its investigational immunomodulator SACCOVID (CD24Fc) has demonstrated significant therapeutic efficacy in the phase III SAC-COVID clinical trial.
Eiger Announces Results of Investigator Sponsored Study in Outpatients with Mild and Uncomplicated COVID-19 prnewswire
September 30, 2020
Eiger BioPharmaceuticals, Inc. announced results of an investigator sponsored study of Peginterferon Lambda-1a (Lambda) in outpatients with mild and uncomplicated COVID-19.
COVAXX Initiates Phase 1 Clinical Trial of COVID-19 Vaccine UB-612 in Taiwan, China Region of China prnewswire
September 30, 2020
COVAXX announced the first healthy adult volunteers were safely dosed in the company's Phase 1, open-label, dose-escalation study of the UB-612 vaccine candidate for COVID-19 in Taiwan, China Region of China.
Immunic, Inc. Announces Results From Interim Safety Analysis and Recruitment Update From Its Ongoing Phase 2 CALVID-1 Trial of IMU-838 in Patients With Moderate COVID-19 prnewswire
September 30, 2020
Immunic, Inc. announced the results of a pre-planned interim safety analysis and a recruitment update from the ongoing phase 2 CALVID-1 trial of its selective oral DHODH inhibitor, IMU-838, in patients with moderate coronavirus disease 2019 (COVID-19).
FDA Grants IND Approval for Phase II Clinical Trial Using Stemedica's itMSC Therapy for COVID-19 Patients prnewswire
September 30, 2020
Stemedica Cell Technologies, Inc. has received U.S. Food and Drug Administration (FDA) Investigational New Drug (IND) approval for "A Phase II, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety ...
Curative Researchers Initiate Research Study to Test Efficacy of Self-Collected COVID-19 Tests prnewswire
September 30, 2020
COVID-19 testing startup Curative, Inc. announced the launch of a new COVID-19 study in the City of San Antonio.
Strong activation of anti-bacterial T cells linked to severe COVID-19 worldpharmanews
September 30, 2020
A type of anti-bacterial T cells, so-called MAIT cells, are strongly activated in people with moderate to severe COVID-19 disease, according to a study by researchers at Karolinska Institutet in Sweden that is published in the journal Science Immunology.
Preventative nasal spray shown to reduce viral replication by up to 96% in COVID-19 challenge study prnasia
September 28, 2020
A novel nasal treatment developed to boost the natural human immune system to fight common colds and flu, has proved remarkably successful in reducing COVID-19 viral replication test results, released today, reveal.
The formula to step up India Nutra Inc’s success expresspharma
September 28, 2020
The dramatic increase in consumer demand for products to improve nutrition and support a strong immune function has opened a huge opportunity for the nutraceuticals industry.
WHO chief lauds India’s assurance to share vaccine production prowess to aid nations fight COVID-19 expresspharma
September 28, 2020
PM Modi had assured that India'sproduction and delivery capacity in vaccines will be used to help all humanity in fighting this crisis at a recent session of the UN General Assembly.